Enhanced QSAR Model Performance by Integrating Structural and Gene Expression Information
暂无分享,去创建一个
Wei Liu | Leihong Wu | Xiaohui Fan | Li Xing | Qian Chen | Xiaohui Fan | Li Xing | Leihong Wu | Qian Chen | Wei Liu
[1] Paola Gramatica,et al. Principles of QSAR models validation: internal and external , 2007 .
[2] M. Fielden,et al. Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. , 2005, Journal of biotechnology.
[3] G. Woods,et al. The two faces of metallothionein in carcinogenesis: photoprotection against UVR-induced cancer and promotion of tumour survival , 2010, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[4] R. Czerminski,et al. Use of Support Vector Machine in Pattern Classification: Application to QSAR Studies , 2001 .
[5] A. Bittner,et al. Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity , 2006, Molecular carcinogenesis.
[6] Xiaohui Fan,et al. Why QSAR fails: an empirical evaluation using conventional computational approach. , 2011, Molecular pharmaceutics.
[7] David Warde-Farley,et al. Dynamic modularity in protein interaction networks predicts breast cancer outcome , 2009, Nature Biotechnology.
[8] Richard Weber,et al. A wrapper method for feature selection using Support Vector Machines , 2009, Inf. Sci..
[9] Markus A Lill,et al. Multi-dimensional QSAR in drug discovery. , 2007, Drug discovery today.
[10] Xiaohui Fan,et al. Reliably assessing prediction reliability for high dimensional QSAR data , 2012, Molecular Diversity.
[11] Robert Stanforth,et al. The quality of QSAR models: problems and solutions , 2007, SAR and QSAR in environmental research.
[12] George Loizou,et al. Development of good modelling practice for physiologically based pharmacokinetic models for use in risk assessment: the first steps. , 2008, Regulatory toxicology and pharmacology : RTP.
[13] Weida Tong,et al. Assessment of Prediction Confidence and Domain Extrapolation of Two Structure–Activity Relationship Models for Predicting Estrogen Receptor Binding Activity , 2004, Environmental health perspectives.
[14] A. Hopkins. Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.
[15] Chih-Jen Lin,et al. LIBSVM: A library for support vector machines , 2011, TIST.
[16] Weida Tong,et al. DNA Microarrays Are Predictive of Cancer Prognosis: A Re-evaluation , 2010, Clinical Cancer Research.
[17] F. Burden,et al. Robust QSAR models using Bayesian regularized neural networks. , 1999, Journal of medicinal chemistry.
[18] Richard M. Simon,et al. A Paradigm for Class Prediction Using Gene Expression Profiles , 2003, J. Comput. Biol..
[19] A. Barabasi,et al. Drug—target network , 2007, Nature Biotechnology.
[20] Y. Liu,et al. Protective effect of metallothionein against the toxicity of cadmium and other metals(1). , 2001, Toxicology.
[21] A. Barabasi,et al. Network medicine : a network-based approach to human disease , 2010 .
[22] M. Cronin,et al. Pitfalls in QSAR , 2003 .
[23] Guillermín Agüero-Chapín,et al. QSAR for RNases and theoretic–experimental study of molecular diversity on peptide mass fingerprints of a new Leishmania infantum protein , 2009, Molecular Diversity.
[24] A. Jayasurya,et al. Metallothioneins in human tumors and potential roles in carcinogenesis. , 2003, Mutation research.
[25] J C Madden,et al. An evaluation of global QSAR models for the prediction of the toxicity of phenols to Tetrahymena pyriformis. , 2008, Chemosphere.
[26] Gergana Dimitrova,et al. A Stepwise Approach for Defining the Applicability Domain of SAR and QSAR Models , 2005, J. Chem. Inf. Model..
[27] Ting Wang,et al. Boosting: An Ensemble Learning Tool for Compound Classification and QSAR Modeling , 2005, J. Chem. Inf. Model..
[28] H. Yamada,et al. The Japanese toxicogenomics project: application of toxicogenomics. , 2010, Molecular nutrition & food research.
[29] Vladimir Frecer,et al. Design, structure-based focusing and in silico screening of combinatorial library of peptidomimetic inhibitors of Dengue virus NS2B-NS3 protease , 2010, J. Comput. Aided Mol. Des..
[30] Weida Tong,et al. Does Applicability Domain Exist in Microarray-Based Genomic Research? , 2010, PloS one.
[31] Manuela Pavan,et al. DRAGON SOFTWARE: AN EASY APPROACH TO MOLECULAR DESCRIPTOR CALCULATIONS , 2006 .
[32] David A Winkler,et al. Predictive Bayesian neural network models of MHC class II peptide binding. , 2005, Journal of molecular graphics & modelling.
[33] Chih-Jen Lin,et al. Combining SVMs with Various Feature Selection Strategies , 2006, Feature Extraction.
[34] Y. Martin,et al. Do structurally similar molecules have similar biological activity? , 2002, Journal of medicinal chemistry.
[35] Jie Liu,et al. Metallothionein protection of cadmium toxicity. , 2009, Toxicology and applied pharmacology.
[36] H. Mewes,et al. Can we estimate the accuracy of ADME-Tox predictions? , 2006, Drug discovery today.
[37] Debadutta Mishra,et al. Elemental alteration, iron overloading and metallothionein induction in experimental hepatocarcinogenesis: a free radical-mediated process? , 2011, Toxicology letters.
[38] Jie Liu,et al. Metallothionein-I/II Double Knockout Mice Are Hypersensitive to Lead-Induced Kidney Carcinogenesis , 2004, Cancer Research.
[39] Igor V. Tetko,et al. Applicability Domains for Classification Problems: Benchmarking of Distance to Models for Ames Mutagenicity Set , 2010, J. Chem. Inf. Model..
[40] S. Bradbury,et al. Quantitative structure-activity relationships and ecological risk assessment: an overview of predictive aquatic toxicology research. , 1995, Toxicology letters.
[41] Vojtech Adam,et al. Metallothioneins and zinc in cancer diagnosis and therapy , 2012, Drug metabolism reviews.
[42] B. Matthews. Comparison of the predicted and observed secondary structure of T4 phage lysozyme. , 1975, Biochimica et biophysica acta.
[43] Li Shao,et al. Consensus Ranking Approach to Understanding the Underlying Mechanism With QSAR , 2010, J. Chem. Inf. Model..
[44] Andrew G Mercader,et al. QSAR study of flavonoids and biflavonoids as influenza H1N1 virus neuraminidase inhibitors. , 2010, European journal of medicinal chemistry.
[45] C. Cobbett,et al. Phytochelatins and metallothioneins: roles in heavy metal detoxification and homeostasis. , 2002, Annual review of plant biology.
[46] Yi Liu,et al. FS_SFS: A novel feature selection method for support vector machines , 2006, Pattern Recognit..
[47] Masayoshi Abe,et al. Carcinogenic risk of copper gluconate evaluated by a rat medium-term liver carcinogenicity bioassay protocol , 2008, Archives of Toxicology.
[48] George Kollias,et al. A combined LS-SVM & MLR QSAR workflow for predicting the inhibition of CXCR3 receptor by quinazolinone analogs , 2010, Molecular Diversity.
[49] Gerald M. Maggiora,et al. On Outliers and Activity Cliffs-Why QSAR Often Disappoints , 2006, J. Chem. Inf. Model..
[50] Arthur M. Doweyko,et al. QSAR: dead or alive? , 2008, J. Comput. Aided Mol. Des..
[51] Michael C. Rosenstein,et al. The Comparative Toxicogenomics Database (CTD): a resource for comparative toxicological studies. , 2006, Journal of experimental zoology. Part A, Comparative experimental biology.